Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The Postgraduate Institute for Medicine (PIM), AcademicCME, and ArcheMedX Launch Innovative Online Learning Series to Address Advancements In Dyslipidemia Management
  • USA - English


News provided by

ArcheMedX

May 05, 2015, 06:35 ET

Share this article

Share toX

Share this article

Share toX

Charlottesville, VA (PRWEB) May 05, 2015 -- ArcheMedX announced today, in collaboration with PIM and AcademicCME, the launch of an innovative continuing medical education (CME) program supported by an independent educational grant from Sanofi US and Regeneron Pharmaceuticals Alliance and powered by the ArcheViewer, a data-driven, e-learning software platform. This new educational program is designed to address advancements in monoclonal antibody therapeutics in dyslipidemia management and is being simultaneously distributed through five of the leading online CE portals including CME University, freeCME, myCME, Open CME, and POWER-PAK.

The broad launch of this educational series by PIM, AcademicCME, and ArcheMedX provides unmatched reach to ensure that clinician learners can efficiently access critical content and a more impactful learning experience through the online channels they have each come to know and trust.

“As our Partnership with ArcheMedX has evolved over the past two years, we continue to benefit from the ArcheMedX innovation and they have now made it possible to manage our content and data in one place, while targeting a nearly limitless audience of clinician learners. Together, we are delivering outstanding learning outcomes and finding even greater efficiency and success!” commented Dr. Timothy Hayes, President of AcademicCME.

Clinicians who participate in this educational series will engage in content developed by world-class faculty and leverage a structured set of learning tools (powered by the ArcheViewer) that enable each learner to:

• archive relevant lessons to their personal ‘learning stream’;
• take and synchronize notes at any moment during the activity;
• set critical reminders that prompt the learners to reflect and apply what they have learned over time;
• search through and review resources (i.e., articles, studies, tools) selected by faculty; and,
• submit questions directly to faculty.

As Joel Selzer, Co-Founder and CEO of ArcheMedX, explains “We developed a federated distribution model that enables educational partners, such as PIM and AcademicCME, to construct a single set of learning activities within the ArcheViewer that can be centrally managed and seamlessly accessed by millions of clinician learners. And since the data is also captured and analyzed centrally within the ArcheViewer, regardless of where the learner accessed the content from, faculty and educational planners can now deliver a truly agile and data-driven educational model to the broadest audience possible."

Access to this new initiative, “Advancements In Monoclonal Antibody Therapeutics In Dyslipidemia Management” is now available for CMEUniversity, freeCME, myCME, OpenCME, and POWER-PAK registered learners. To learn more about these pioneering CME programs, please contact Dr. Timothy Hayes at thayes(at)academiccme(dot)com For additional information on the ArcheMedX e-learning delivery and real-time analysis solutions, including the ArcheViewer e-learning platform, please contact Joel Selzer, CEO of ArcheMedX, at joel(at)archemedx(dot)com.

--
About PIM
The Postgraduate Institute for Medicine (PIM) is nationally accredited to certify education and issue continuing education credit to a multidisciplinary audience of learners. PIM is recognized for the highest level of excellence by being awarded Accreditation with Commendation by the ACCME and Accredited with Distinction by the ANCC. PIM specializes in joint providership, outcomes measurement, and grant solicitation/funding support; PIM also offers an online eLearning platform with traffic guarantees, cmeuniversity.com.

About AcademicCME
AcademicCME is a physician-run, healthcare solutions medical education company designed to impact practice behavior and thus patient outcomes. AcademicCME leadership draws on the more than 45 years of clinical experience of its staff physicians in clinical practice and education, which provides a unique understanding of the dynamics between physician behavior, patient care and practice based educational needs. Visit academiccme.com for more information.

About ArcheMedX
ArcheMedX is a healthcare informatics and e-learning technology company that is transforming online learning in medicine through an agile, data-driven approach to e-learning that improves competency and performance among healthcare professionals. By engineering an informatics‐powered architecture that organizes and connects the natural learning actions of clinicians in one system, ArcheMedX simplifies lifelong learning and streamlines the process of educational planning, assessment and support. Visit archemedx.com for more information.

Joel Selzer, ArcheMedX, 434-260-1850, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.